Table 3.
Outcomes of embolization from the 16 studies published from 1995 with at least 20 participants with mean follow up greater than 1 month
| N | Major complications (n) | Long-term success | Coagulopathic patientsa | |
|---|---|---|---|---|
| Current study | 62 | 0 | 90.4% | 36.8% |
| Wang 2016 | 43 | 1 | Not clear | Not mentioned |
| Gottumukkala 2013 | 84 | 2 | Not clear | 23.8%b |
| Strach 2011 | 48 | 2 | 90.7% | Not mentioned |
| Santaolalla 2009 | 28 | 1 | 85.7% | 28.6%b |
| Christensen 2005 | 70 | 1 | Not clear | Not mentioned |
| Vokes 2004 | 28 | 0 | 86% | Not mentioned |
| Ricci 2004 | 22 | 0 | 81.8% | Not mentioned |
| Oguni 2000 | 37 | 0 | Not clear | 2.7% |
| Leppanen 1999 | 37 | 2 | 78.4% | Not mentioned |
| Moreau 1998 | 45 | 2 | 84.1% | 6.7% |
| Tseng 1998 | 107 | 2 | Not clear | 3.7% |
| Elahi 1995 | 54 | 1 | 85.2% | 1.9% |
a
Hereditary haemorrhagic telangiectasia subsets excluded.
b
Includes aspirin use.